11-17645578-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM5BP4_StrongBP6BS2
The NM_001292063.2(OTOG):c.8476C>T(p.Arg2826Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00255 in 1,550,572 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2826H) has been classified as Pathogenic.
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.8476C>T | p.Arg2826Cys | missense_variant | 55/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.8512C>T | p.Arg2838Cys | missense_variant | 54/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.8476C>T | p.Arg2826Cys | missense_variant | 55/56 | 5 | NM_001292063.2 | ENSP00000382329 | P2 | |
OTOG | ENST00000399391.7 | c.8512C>T | p.Arg2838Cys | missense_variant | 54/55 | 5 | ENSP00000382323 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00212 AC: 323AN: 152216Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00217 AC: 323AN: 148796Hom.: 1 AF XY: 0.00222 AC XY: 178AN XY: 80154
GnomAD4 exome AF: 0.00260 AC: 3634AN: 1398238Hom.: 11 Cov.: 31 AF XY: 0.00252 AC XY: 1738AN XY: 689638
GnomAD4 genome AF: 0.00211 AC: 322AN: 152334Hom.: 1 Cov.: 33 AF XY: 0.00204 AC XY: 152AN XY: 74490
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | OTOG: BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 12, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 24, 2015 | p.Arg2838Cys in exon 54 of OTOG: This variant is not expected to have clinical s ignificance because it has been identified in 0.4% (20/5018) of European chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs191662816). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jul 17, 2015 | - - |
OTOG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at